Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias

Circulation Journal

Volumn 70, Issue 8, 2006, Pages 977-984

  Satomi, Kazuhiro ^a   Kurita, Takashi ^a   Takatsuki, Seiji ^b   Yokoyama, Yasuhiro ^c   Chinushi, Masaomi ^d   Tsuboi, Naoya ^e   Nitta, Takashi ^f   Shoda, Morio ^g   Mitamura, Hideo ^h  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YOKOSUKA KYOSAI HOSPITAL   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h SAISEIKAI CENTRAL HOSPITAL   (Japan)

Author keywords

Amiodarone; Implantable cardioverter defibrillator; Prognosis; Ventricular arrhythmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEFIBRILLATOR; DEMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; PROSPECTIVE STUDY; QUESTIONNAIRE; SURVIVAL RATE; THYROID DISEASE;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION;

EID: 33746689159     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.977     Document Type: Article

References (27)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940.
3. Domanski MJ, Saksena S, Wyse G, Hallstrom A, Schron EB, Nanda A, et al. Clinical and socioeconomic profile of patients with malignant ventricular arrhythmias in 1993 to 1995. AVID investigators. Antiarrhythmics Versus Implantable Defibrillator. Am J Cardiol 1997; 80: 299-301.
4. Kitamura S, Satomi K, Kurita T, Shimizu W, Suyama K, Aihara N, et al. Long term follow-up of transvenous defibrillation leads: High incidence of fracture in coaxial polyurethane lead. Circ J 2006; 70: 273-277.
5. Pacifico A, Johnson J, Stanton M. Comparison of results in two implantable defibrillators. Am J Cardiol 1998; 82: 875-880.
6. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Sanjeev H, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 1999; 340: 1855-1862.
7. Aiba T, Kurita T, Taguchi A, Shimizu W, Suyama K, Aihara N, et al. Long-term efficacy of empirical chronic amiodarone therapy in patients with sustained ventricular tachyarrhythmia and structural heart disease. Circ J 2002; 66: 367-371.
8. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999; 100: 2025-2034.
9. Sim I, McDonald KM, Labori P, Norbuas C, Hlatky M. Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation 1997; 96: 2823-2829.
10. Dolack GL. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial): Cardiac arrest in seattle, conventional versus amiodarone drug evaluation. Am J Cardiol 1994; 73: 237-241.
11. The Cascade Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest. Am Heart J 1993; 72: 280-287.
12. Kuhlkamp V, Mewis C, Suchalla R, Mermi J, Dornberger V, Seipel L. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment. Int J Cardiol 1999; 69: 271-279.
13. Pelosi F Jr, Oral H, Kim MH, Sticherling C, Horwood L, Knight BP, et al. Effect of chronic amiodarone therapy on defibrillation energy requirements in humans. J Cardiovasc Electrophysiol 2000; 11: 736-740.
14. Nielsen T, Hamdan M, Kowal R, Barbera S, Page R, Joglar J. Effect of acute amiodarone loading on energy requirements for biphasic ventricular defibrillation. Am J Cardiol 2001; 88: 446-448.
15. Kurita T, Mitamura H, Aizawa Y, Nitta T, Aonuma K, Tsuboi N, et al. Japanese randomized trial for investigation of a combination therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: The Nippon ICD Plus Pharmacologic Option Necessity (NIPPON) study design. Circ J 2006; 70: 316-320.
16. Tokano T, Bach D, Chang J. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovac Electrophysiol 1998; 9: 791-797.
17. Joglar J, Kessler D, Welch P. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am Heart J 1999; 83: 270-272.
18. de Vries J, Bakker P, Visser G, Diephuis J, van Huffelen A. Changes in cerebral oxygen uptake and cerebral electrical activity during defibrillation threshold testing. Anesth Analg 1998; 87: 16-20.
19. Hegel M, Griegel L, Black C, Goulden L, Ozahowski T. Anxiety and depression in patients receiving implanted cardioverter-defibrillators. Int J Psychiatry Med 1997; 27: 57-69.
20. Bourke J, Turkington D, Thomas G, McComb J, Tynan M. Florid psychopathology in patients receiving shocks from implanted cardioverterdefibrillators. Heart 1997; 78: 581-583.
21. Movsowitz C, Marchlinski FE. Interactions between implantable cardioverter-defibrillators and class III agents. Am J Cardiol 1998; 82: 41I-48I.
22. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainidem flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-788.
23. Buxton MJ, Lee KL, Fischer J, Josephson M, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882-1890.
24. Cairns J, Connelly S, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675-682.
25. Julian D, Camm A, Frangin G, Janse M, Munoz A, Schwartz P, et al. Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction. Lancet 1997; 349: 667-674.
26. Investigators ATMA. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997; 350: 1417-1424.
27. Brandy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.